The Global Gadolinium-157 Market was valued at USD 1.65 million in 2025 and is projected to reach USD 4.35 million by 2034, growing at a Compound Annual Growth Rate (CAGR) of 15.3% during the forecast period (2025-2034). This significant growth is driven by expanding nuclear power infrastructure, advancements in medical imaging technologies, and emerging applications in scientific research.

As the demand for this rare earth isotope increases across critical industries, specialized producers are scaling production capabilities and investing in purification technologies. In this analysis, we examine the Top 10 Companies in the Gadolinium-157 Market—the specialized manufacturers, nuclear suppliers, and medical isotope providers shaping this high-value sector.

---

🔟 1. Rosatom (TVEL Fuel Company)

Headquarters: Moscow, Russia
Key Offering: Nuclear-grade Gadolinium-157 metal and compounds

Rosatom’s isotope division leads global production of enriched Gadolinium-157 for nuclear applications. As a vertically integrated nuclear enterprise, the company supplies isotopes for reactor control rods and radiation shielding across Eurasian power plants.

Key Capacities:

• Operates the only large-scale Gd-157 enrichment facility
• 40% market share in nuclear applications
• Annual production capacity exceeding 300 kg

---

9️⃣ 2. Neonest AB

Headquarters: Stockholm, Sweden
Key Offering: Research-grade Gadolinium-157 with 99.9% isotopic purity

This Swedish specialist provides ultra-high purity Gd-157 to European research institutions and technology companies. Neonest’s proprietary electromagnetic separation process delivers isotopes for quantum computing and neutron detection applications.

Key Capacities:

• Supplies CERN and other advanced research facilities
• Pioneer in compact isotope separation technologies
• Developing medical-grade Gd-157 formulations

---

8️⃣ 3. Japan Nuclear Fuel Limited (JNFL)

Headquarters: Aomori, Japan
Key Offering: Reactor-grade Gadolinium-157 compounds

JNFL produces specialized neutron absorbers containing Gd-157 for Japan’s nuclear power plants. The company’s R&D focuses on improving burnup characteristics and longevity of gadolinium-based control rods.

Key Capacities:

• Exclusive supplier to 7 Japanese nuclear plants
• Operates the Rokkasho Enrichment Plant
• ISO 9001 certified production facilities

Download FREE Sample Report:
Gadolinium-157 Market – View in Detailed Research Report

---

7️⃣ 4. ISOFLEX USA

Headquarters: San Francisco, California, USA
Key Offering: Medical and research-grade Gadolinium-157

ISOFLEX specializes in high-value isotopic materials for medical and scientific applications. The company produces Gd-157 for contrast agent development and neutron therapy research.

Key Capacities:

• FDA-registered production facility
• Supplies 5 major radiopharmaceutical companies
• 100 g/month production capacity

---

6️⃣ 5. NIDC (Nuclear Industry Development Corporation)

Headquarters: Beijing, China
Key Offering: Industrial and nuclear Gadolinium-157 products

This Chinese state-owned enterprise leads domestic production of enriched gadolinium isotopes. NIDC supplies both domestic nuclear plants and international research customers through licensed channels.

Key Capacities:

• Controls 60% of Chinese Gd-157 supply
• Annual capacity of 200 kg
• Developing next-gen isotope separation technologies

---

5️⃣ 6. Trace Sciences International

Headquarters: Toronto, Canada
Key Offering: Ultra-high purity Gadolinium-157 isotopes

Trace Sciences provides rare isotopes to North American nuclear and medical research institutions. The company’s precision separation techniques yield some of the purest Gd-157 materials available commercially.

Key Capacities:

• 99.99% isotopic purity available
• Canadian Nuclear Safety Commission licensed
• Supplies NASA space radiation shielding programs

---

4️⃣ 7. Eckert & Ziegler Isotope Products

Headquarters: Berlin, Germany
Key Offering: Medical Gadolinium-157 formulations

This German specialist focuses on medical applications of rare isotopes. The company develops gadolinium-based contrast agents and therapeutic compounds for European healthcare markets.

Key Capacities:

• EU-GMP certified production
• Supplies over 50 hospitals and research centers
• 50 g/month production capacity

---

3️⃣ 8. IRE ELiT

Headquarters: Fleurus, Belgium
Key Offering: Cyclotron-produced Gadolinium-157

IRE ELiT pioneers alternative production methods for medical isotopes. Their cyclotron-based approach provides reliable supplies of Gd-157 for European radiopharmaceutical applications.

Key Capacities:

• Alternative to traditional enrichment methods
• 30 g/month production capacity
• EMA-approved quality standards

---

2️⃣ 9. Isotope JSC

Headquarters: Obninsk, Russia
Key Offering: Industrial-scale Gadolinium-157 products

This Russian enterprise commercializes gadolinium isotopes for industrial and energy applications. The company supplies both domestic and international nuclear technology customers.

Key Capacities:

• 200 kg annual production capacity
• Provides customized gadolinium compositions
• Strategic partner to Rosatom

Download FREE Sample Report:
Gadolinium-157 Market – View in Detailed Research Report

---

1️⃣ 10. National Isotope Development Center (NIDC USA)

Headquarters: Oak Ridge, Tennessee, USA
Key Offering: Research and medical Gadolinium-157 isotopes

The U.S. Department of Energy’s isotope program provides stable isotopes for scientific and medical applications. NIDC coordinates domestic Gd-157 production and distribution through national laboratories.

Key Capacities:

• Manages production at ORNL and other national labs
• Supplies U.S. government research programs
• 100 g/month allocation capacity

---

🌍 Outlook: Expanding Horizons for Gadolinium-157 Applications

The Gadolinium-157 market is entering a phase of dynamic growth as new applications emerge beyond traditional nuclear uses. While power generation remains the largest application segment, medical diagnostics and advanced research are driving market expansion.

📈 Key Trends Shaping the Market:

• Nuclear plant construction in Asia increasing demand
• Medical imaging advancements requiring higher purity isotopes
• Space exploration driving radiation shielding requirements
• Quantum computing research creating new industrial demand
• Supply chain diversification efforts in Western markets

Get Full Report Here:
Gadolinium-157 Market – View in Detailed Research Report

The companies profiled above are not only meeting current demand—they’re developing the next generation of gadolinium-based solutions that will shape nuclear safety, medical diagnostics, and technological innovation.